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Abstract
Purpose of Review To critique the evidence from recent and
ongoing obesity prevention interventions in the first 1000 days
in order to identify evidence gaps andweaknesses, and tomake
suggestions for more informative future intervention trials.
Recent Findings Completed and ongoing intervention trials
have had fairly modest effects, have been limited largely to
high-income countries, and have used relatively short-term
interventions and outcomes. Comparison of the evidence from
completed prevention trials with the evidence from systematic
reviews of behavioral risk factors shows that some life-course
stages have been neglected (pre-conception and toddlerhood),
and that interventions have neglected to target some important
behavioral risk factors (maternal smoking during pregnancy,
infant and child sleep). Finally, while obesity prevention in-
terventions aim to modify body composition, few intervention
trials have used body composition measures as outcomes, and
this has limited their sensitivity to detect intervention effects.
The new WHO Healthy Lifestyles Trajectory (HeLTI) initia-
tive should address some of these weaknesses.
Summary Future early obesity prevention trials should be
much more ambitious. They should, ideally: extend their inter-
ventions over the first 1000 days; have longer-term (childhood)
outcomes, and improved outcomemeasures (body composition
measures in addition to proxies for body composition such as
the BMI for age); have greater emphasis on maternal smoking
and child sleep; be global.
Keywords Early-life interventions . Obesity prevention .
Pediatric obesity . Infants . Children . Review
Introduction
As the obesity pandemic has evolved, research efforts aimed
at addressing it have increasingly focused on the opportunities
for prevention which exist in early life. For the purposes of the
present review early life is defined as pre or peri-conception,
pregnancy, infancy, and early childhood (up to age 24months),
i.e., equivalent to the “first 1000 days” of life. This trend
towards an emphasis on early-life obesity prevention was
expressed in the recent Ending Childhood Obesity Report
[1•] which highlighted the central importance of environmen-
tal modifications during pre-conception, pregnancy, infancy,
and early childhood. Figure 1a demonstrates the rapidly in-
creasing numbers of obesity prevention interventions in early
life, as revealed by systematic reviews [2•, 3–6] published
between 2002 and 2016.
Two fundamental arguments have been made for the in-
creased focus on early-life preventive interventions. First, a
number of common behavioral factors (including biological
factors which are highly amenable to modification by behavior
change, such as rapid infant growth) in early life substantially
increase the risk of later obesity through establishing lifestyle
habits which are obesogenic, and/or by “programming” of bi-
ological processes (such as appetite regulation) at critical times
in development. There is now a substantial literature on early-
life behavioral risk factors for childhood obesity, summarized
and synthesized in recent systematic reviews. Monasta et al.
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[7] concluded that there was well-established evidence for the
following risk factors: maternal diabetes; maternal smoking;
rapid infant growth; no or limited breastfeeding; infant obesity;
low physical activity in early childhood; short sleep duration in
early childhood; and sugar-sweetened drink consumption in
early childhood. More recently, Woo-Baidal et al. [8] conclud-
ed that the following early-life risk factors were very well-
established: higher maternal pre-pregnancy weight status
(e.g., body mass index—BMI); prenatal exposure to tobacco;
excess maternal weight gain during pregnancy; higher infant
birth weight; and rapid infant weight gain. Woo-Baidal et al.
[8] also found that the following risk factors were fairly well-
established: gestational diabetes; child care attendance; short
sleep duration; introduction of complementary feeding before
4 months of age; and use of antibiotics in infancy. The second
fundamental argument for preventive intervention in early life
lies in the increasing concern over social inequalities in obesi-
ty—the generally higher risk of obesity with lower socio-
economic (SES) in high-income countries [8, 9]. These social
inequalities are already very marked by early childhood, and
may be widening in high-income countries [10]. An emerging
body of evidence suggests that targeting the well-established
early-life behavioral risk factors for obesity (many of which are
markedly socially patterned) may be particularly effective for
reducing social inequalities in obesity [11•].
While early-life prevention of obesity is increasingly im-
portant to researchers [1•], it is a relatively new concept to
many outside the pediatric obesity research community.
There remains a good deal of uncertainty as to how best to
turn the principles of early-life prevention into practical and
effective strategies which can be incorporated into policy. The
present review aims to critique the evidence base on early-life
preventive interventions by providing evidence-based an-
swers to the following research questions:
1. Where, geographically, have the early-life obesity preven-
tion interventions taken place?;
2. Which life-course stages have research interventions fo-
cused on?;
3. Which of the well-established behavioral risk factors have
research interventions targeted, and which have been
neglected?;
Fig. 1 a Number of obesity prevention interventions in early life (first
1000 days) identified by successive systematic reviews. b Number of
completed and ongoing early-life interventions by geographical region
[2•]. c Number of early-life obesity prevention interventions by life-
course stages [2•]. d Number of early-life obesity prevention studies
reporting body composition (body fatness) outcomes [2•]
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4. What is the efficacy of early-life preventive interventions?;
5. To what extent is the evidence on efficacy of preventive
interventions limited by study outcome measures?
Methods
Since the present review aimed to critique the evidence on
early-life childhood obesity prevention interventions, it was
important that the critique was applied to a recent and com-
prehensive summary of relevant evidence. The 2016 sys-
tematic review by Blake-Lamb et al. [2•] on interventions
for prevention of obesity in the first 1000 days of life was
identified as a very good basis for the present critique. The
Blake-Lamb et al. review [2•] addressed research questions
which were distinct to those of the present critique, and was
particularly useful in that it included ongoing (registered)
trials as well as completed trials, so could provide some
indication of future as well as past research efforts in this
area. The relevance of the Blake-Lamb et al. review [2•] to
the present critique was confirmed formally, using the rele-
vance domain of the risk of bias in systematic reviews
(ROBIS) method [12].
Results
Evidence-Based Answers to Our Research Questions
Question 1: Where, Geographically, Have Early-Life Obesity
Prevention Interventions Taken Place?
While obesity is pandemic, and is placing a large and rapidly
increasing burden on low-middle-income countries [1•, 10]
the early-life obesity prevention intervention studies reviewed
to date are far from global. Figure 1b illustrates the extent to
which previous and ongoing trials have been biased towards
high-income nations: of the 26 completed trials included in the
review by Blake-Lamb et al. [2•] only 5 were from middle-
income countries and none were from low-income countries,
using the classification of national income status provided by
theWorld Bank in 2016 (Blogs.worldbank.org/opendata/new-
country-classifications2016); of the 47 ongoing trials
identified by Blake-Lamb et al. [2•] only 6 were from
middle-income countries and none were from low-income
countries. Searching for studies published in English may
have biased the search results to some degree against studies
from low- and middle-income nations, but the lack of evi-
dence from low- and middle-income countries is both stark
and unfortunate.
Question 2: Which Life-Course Stages Have Been Targeted
in Early-Life Obesity Prevention Interventions?
While early-life prevention of obesity encompasses any or all
of the four potential life-course stages (pre-conception; preg-
nancy; infancy; early childhood, i.e., up to 24 months) con-
sidered by the present review, our critique shows that the ev-
idence base to date is biased towards pregnancy and infancy
(Fig. 1c). Of the 26 completed trials identified by Blake-Lamb
et al. [2•], no trials focused on pre-conception, 6 started during
pregnancy and continued into infancy, 2 were pregnancy-only
interventions, and 18 began their intervention during infancy.
Blake-Lamb et al. [2•] identified a further 47 ongoing trials,
and these provide a more current picture of the target popula-
tions in intervention studies. Among these 47 ongoing studies
no trials targeted the pre-conception periods, 20 targeted preg-
nancy, 16 targeted pregnancy and infancy, and 11 focused on
infancy (some of which extended interventions into early
childhood).
In summary, published evidence is lacking from interven-
tions which range across all four of the life-course stages, from
interventions targeting pre- or peri-conception, and from in-
terventions targeting the period 12–24 months of postnatal
life. As noted above, multiple well-established and modifiable
behavioral risk factors for obesity prevention exist during
these “neglected” life-course stages (e.g., pre-pregnancy over-
weight and obesity; maternal smoking pre-pregnancy or dur-
ing pregnancy; early childhood sleep, physical activity, and
sugar-sweetened drink consumption).
Question 3: Which Behavioral Risk Factors Have Been
Targeted in Early-Life Obesity Prevention Interventions,
and Which Have Been Neglected?
Many well-established and modifiable early-life risk factors
for obesity have been identified [7, 8]. In this section, we
consider the extent to which the evidence of behavioral targets
from preventive interventions maps onto the intervention ev-
idence summarized by Blake-Lamb et al. [2•].
Risk Factors Targeted During Pre-conception Interventions
As noted above, none of the 73 trials identified by Blake-
Lamb et al. [2•] focused on this stage of the life-course, and
so no critique of the risk factors which were targeted was
possible.
Risk Factors Targeted During Pregnancy Among the 26
completed trials identified by Blake-Lamb et al. [2•], 2 fo-
cused on pregnancy only—neither targeted maternal smoking.
Among the 47 ongoing trials identified, 20 focused on preg-
nancy (1 on managing gestational diabetes; 2 on fatty acid
supplementation; 17 on maternal diet and/or physical activi-
ty). As with the completed trials, it appears that maternal
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smoking has been neglected as a potential intervention target,
and a number of trials have targeted risk factors which are not
particularly strongly supported by the evidence.
Risk Factors Targeted During Both Pregnancy and
Infancy Of the 6/26 completed trials which extended inter-
ventions across both pregnancy and infancy, 2 focused on
targets not firmly established as risk factors for obesity
(probiotics to alter infant gut microbiota; essential fatty acid
supplementation); 2 focused on diet only (infant feeding);
only 2 intervention trials targeted multiple behaviors
(breastfeeding, complementary feeding, infant physical activ-
ity, family physical activity and diet in one trial; maternal diet
and physical activity, infant and child feeding and physical
activity, infant sedentary behavior and infant sleep in the oth-
er), not all of which were well-established as risk factors for
childhood obesity. None of the trials appear to have targeted
maternal smoking. The evidence base from completed
pregnancy-infancy interventions is therefore quite limited,
and does not map on to the evidence base on risk factors
particularly well.
Among the ongoing trials during both pregnancy and in-
fancy identified by Blake-Lamb et al. [2•], most (26 of 27)
focused on pregnancy and infancy, while 1/27 extended the
intervention from late infancy into early childhood: 2 used
modified infant formula; 1 targeted breastfeeding promotion
and another 1 targeted complementary feeding modification.
The remaining 22 trials all involved multi-component inter-
ventions (diet, physical activity, only occasionally other risk
factors such as sleep) targeting infants only (2 trials) or parents
only (usually mothers, 8 trials) or both maternal and infant
behaviors (12 trials). The behavioral targets of ongoing inter-
ventions in the pregnancy and/or infancy periods therefore
map slightly better onto the risk factor evidence than the com-
pleted trials, but there remains a lack of emphasis on the
targeting of maternal smoking, and a relative lack of trials
focusing on the modification of infant sleep.
Risk Factors Targeted During Infancy and/or Early
Childhood Of the 18 completed trials of interventions which
encompassed infancy only, early childhood only, or which
crossed infancy-early childhood, 1/6 targeted infant sleep on-
ly, 1 targeted infant sleep combined with infant feeding; 4
targeted maternal/family diet and physical activity combined;
4 targeted infant feeding only, and 2 targeted infant feeding
with physical activity and/or sedentary behavior; 4/18
attempted to modify infant growth via altering the composi-
tion (protein content or composition) of formula; 2/18 focused
on less well-established potential biological risk factors (alter-
ing infant or maternal fatty acid intake). In summary, the ex-
tent to which the behavioral targets of these interventions
mapped onto the behavioral risk factor evidence was quite
limited. Specifically, in these 18 completed interventions there
was limited targeting of sleep, and very limited targeting of
physical activity, and sugar-sweetened drink consumption.
There was also limited emphasis on the 12–24 month postna-
tal age.
Of the 11 ongoing trials in infancy, early childhood (12–
24 months), or which crossed infancy and early childhood, 6
were in infants only: 2 involved modifications to infant for-
mula; 2 targeted breastfeeding and complementary feeding; 2
were multi-component (infant feeding, physical activity, sed-
entary behavior and sleep). A single trial focused on the 12–
24 month period only, and it targeted diet, physical activity,
and sleep. All 4 of the trials which crossed both infancy and
early childhood were multi-component, targeting infant feed-
ing and infant/child/family diet, and physical activity; one trial
also targeted sleep. The ongoing trials seem to have targeted a
higher proportion of the behavioral risk factors than the com-
pleted trials, though sleep was under-represented as a target.
Question 4: What is the Efficacy of Early-Life Preventive
Interventions to Date?
Future policy interventions would benefit from clear and con-
sistent evidence of efficacy (e.g. from randomized controlled
trials—RCT), effectiveness (e.g., application of the interven-
tion beyond RCT, and scale-up), and cost-effectiveness of
interventions. Of the 26 completed trials included in the re-
view by Blake-Lamb et al. [2•] evidence of at least some
efficacy, in the form of a statistically significant benefit to
the intervention, was found in 11 studies. There maywell have
been publication bias, favoring the publication of trials with
evidence of efficacy, though a strong bias in the opposite
direction arises from the choice of outcome measures,
discussed below. Many of the trials were limited: relatively
short-term interventions in many cases; small (some were pi-
lot studies); most had relatively short-term follow-up so could
not provide evidence on effects into childhood; there was
evidence of attenuation of intervention effects over time
[e.g., 13]. Even when efficacy was established, for multi-
component interventions (i.e., those which targeted more than
one risk factor or behavior) it is difficult to attribute efficacy to
the different components with any confidence.
In general, intervention effects seemed promising, but were
of uncertain longer-term significance (given possible attenua-
tion of intervention effects), and public health significance.
For example, Navarro et al. [14] had a mean beneficial effect
on child BMI z-score of −0.31 (CI 0.12 to 0.49) at 15–
24 months; Wen et al. [15] found a lower mean child BMI
of 0.29 kg/m2 (CI 0.02 to 0.55) at 24 months; Daniels et al.
[13] found a mean intervention effect of 0.19 on BMI z-score
at 13–15 months of age which had attenuated and was non-
significant at 24 months of age. Taken together, the evidence
to date suggests that efficacious interventions generally have
modest effects on BMI. Achieving more substantial and
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longer-term effects might require interventions across several/
all of the life-course stages considered by the present critique,
so that by the achievement of multiple but modest additive
effects the cumulative/overall effects are increased. The major
exception to this is the trial of modification of the protein
content of infant formula by Koletzsko and colleagues [16].
It hypothesized to reduce the rate of infant growth by reducing
the protein content of formula so that it more closely resem-
bled that of breast milk [16]. This trial was notable for provid-
ing evidence of both long-term effects on obesity as an out-
come, and for demonstrating effects which were more sub-
stantial than the other trials: increased risk of obesity at age
6 years in the higher protein formula group (adjusted odds
ratio 2.43, CI 1.12 to 5.27) [16].
Question 5: To What Extent is the Evidence on Efficacy Likely
to Have Been Limited by Choice of Outcome Measure?
The 26 completed trials reviewed by Blake-Lamb et al. [2•]
aimed to modify body composition (body fatness) favorably,
but few measured body composition as an outcome as illus-
trated by Fig. 1d. One study had a measure of body fatness as
an outcome, 1 had a measure of body fatness and a proxy for
body fatness (BMI z-score), and the other 24 used proxies for
body fatness (BMI z-score in most cases, or weight for height
or length in a few, or single or multiple skinfolds in a few
studies). There is substantial evidence that more direct mea-
sures of body composition, rather than crude proxies for body
composition, are more likely to identify effects in pediatric
clinical intervention trials [17]. Our recent longitudinal studies
on the etiology of childhood obesity have been able to identify
associations with exposures, such as sedentary behavior, when
we have used measures of changes in body fatness as out-
comes, but not when we have used proxies for change in body
fatness (e.g., change in BMI or BMI z-score) in the same
analyses [18]. Finally, our systematic review on physical ac-
tivity in the etiology of childhood obesity found that associa-
tions between physical activity-adiposity (and effects of phys-
ical activity on adiposity in intervention studies) were much
more likely to be identified when measures of body composi-
tion were used as outcome measures, rather than crude proxies
for body composition such as BMI [19].
It should also be noted that the advantages of having a
measure of body composition or change in body composition
may not require especially sophisticated measures; even rela-
tively simple field measures such as bio-electrical impedance
can bring substantial benefit over proxy measures [18]. At
present, the “criterion” measures of body composition with
high accuracy are the multi-component methods. They require
combined measurement of body density and total body water
for a “three component” model measure of body composition
and measurement of body density, total body water, and total
body mineral for a “four component” model measure [20].
Multi-component measures are not practical for large field
studies in obesity prevention. However, total body water mea-
surement with stable isotope dilution is a highly accurate “ref-
erence method” [20, 21], with negligible bias. It is also much
more suitable for field use than the criterion methods, and with
an increasing body of evidence on its successful use in field
studies in low-middle-income countries [21].
The above critique of BMI-for-age as an outcome measure
does not negate its value as a simple obesity screening tool for
clinical use, and for population surveillance of obesity.
Systematic reviews have established that it has high specific-
ity for identifying the fattest children and adolescents, and
those with cardio-metabolic risk factors and co-morbidities,
though with only moderate sensitivity [22–24]. However, fu-
ture interventions would benefit from the use of body compo-
sition measures as outcomes (in addition to proxies such as
BMI z-score).
Discussion
The present critique was based on a very recent and highly
relevant systematic review of interventions to prevent obesity
in the first 1000 days [2•], and so our research questions have
answers which are both current and highly evidence-based.
The main findings of our critique are the quantification of a
number of substantial gaps in the evidence on interventions
for obesity prevention during the “first 1000 days”, and the
identification of mismatches between the behavioral risk fac-
tor evidence and the intervention evidence. In particular, there
was a clear lack of evidence from low- and middle-income
countries, from pre-conception interventions, from interven-
tions which extended over all four important stages of the life-
course, from interventions in the period 12–24 months, from
interventions which target some of the well-established risk
factors (notably maternal smoking during pregnancy), a rela-
tive lack of interventions targeting some other well-
established risk factors (e.g., sleep during infancy and child-
hood), and a lack of interventions with body composition
measures as outcomes. Future research might usefully focus
on these major gaps in the evidence.
Addressing the gaps and mismatches in the evidence iden-
tified by the present critique is not straightforward, and would
require funding for intervention trials which is larger and more
long-term than is usually available. For example, conducting
the necessary intervention study which: runs from pre-
conception to age 2 years, matches the intervention targets
to the well-established behavioral risk factors, has higher qual-
ity and much longer-term outcome measures, (and extends—
ideally—from efficacy to effectiveness and cost-effective-
ness), would clearly be challenging in terms of the cost of
the work/the long-term nature of funding required.
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Nonetheless, the current and future global burden of child-
hood obesity warrants an effort of this kind [1•, 25].
A major new research project coordinated by WHO,
starting in 2017, the Healthy Lifestyle Trajectories Initiative,
HeLTI (http://www.cihr-irsc.gc.ca/e/49510.html) could help
fill many of the gaps in the intervention evidence base
identified by the present critique. The HeLTI will use
intervention cohorts and aims to (i) target interventions on
the most important behavioral risk factors, (ii) extend inter-
ventions over many of the early life-course stages covered by
the present review, (iii) base the cohorts in low-middle-income
countries. The HeLTI, and future studies along similar lines,
should be able to test the hypothesis suggested by the present
critique that achieving a substantial impact on obesity preven-
tion in early life will require modifications to multiple behav-
ioral risk factors, extending over multiple life-course stages.
Future targeting of well-established behavioral risk factors,
which have been identified as neglected by the present cri-
tique, will not be straightforward. For example, there is a
substantial literature on interventions to help women
stop/reduce smoking during pregnancy. This is a behavioral
change which has proved difficult to achieve, but was achiev-
able [e.g., 26]. A further difficulty is that families and
healthcare practitioners, at least in high-income western coun-
tries, commonly have strongly held views about the early
behavioral risk factors for obesity which are at odds with the
evidence. For example, mothers and health visitors (commu-
nity nurses with responsibility for the health of mothers, in-
fants, and toddlers) in one English study reported the follow-
ing strongly held views: infancy was “too early” to intervene
for obesity prevention, and there was considerable potential
for harm in doing so; infant crying was always a signal of
hunger; and babies “cannot be overfed” [27]. Clearly, research
and policy interventions must address such strong cultural
barriers to early obesity prevention. Stressing the minimal
potential for harm and the substantial potential benefit of
targeting the behavioral risk factors in the first 1000 days
may be helpful. In advocacy for the required larger and
longer-term funding, for policy change, or for addressing cul-
tural barriers to change, it may be worth reiterating the low
risk and many important co-benefits to the main behavioral
changes required for obesity prevention: maternal smoking
cessation/reduction; adequate maternal physical activity and
healthy body weight and composition pre-conception; healthy
weight gain during pregnancy; appropriate breastfeeding and
complementary feeding; improved sleep in infancy and early
childhood; reductions in sugar-sweetened drink consumption
in early childhood; promotion of infant and early childhood
physical activity. All of these changes should bring substantial
and long-lasting benefits to maternal and child health and
well-being. Finally, theory and evidence-based behavioral in-
terventions to improve the health of adolescents in low-
middle-income countries are now becoming available [e.g.,
28], and these have the potential to deal with the evidence
gap from such countries, and the gap relating to the pre-
conception stage of the life course highlighted by the present
critique.
Conclusions
Future research interventions aiming to prevent obesity in ear-
ly life should, where possible, be more global with a much
greater emphasis on populations in low-middle-income coun-
tries where childhood obesity is now prevalent, be careful to
map intervention targets on to the behavioral risk factor evi-
dence, be longer-term with both longer-term interventions
(ideally extending over much or all of the first 1000 days,
gaining from cumulative/additive intervention effects) and
longer-term outcomes (extending into childhood) and use
body composition measures as outcomes in addition to simple
proxies for body composition such as BMI for age.
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